Page not found
Search results
-
Vanderbilt-Ancora partnership advances research for Charcot-Marie-Tooth disease
... “Reviewing the work of Professor Sanders’ lab was a strong reminder of the caliber and translational quality of research that comes ...
sommers - 11/17/2020 - 2:53pm
-
Vanderbilt University anti-inflammatory therapy licensed to Amytrx is now in clinical trials for eczema treatment
10/29/2020 ...
sommers - 10/30/2020 - 12:45pm
-
Vanderbilt biochemists reveal the cause of Charcot-Marie-Tooth disease
10/29/2020 ...
sommers - 10/30/2020 - 12:43pm
-
Vanderbilt Start up SkyNano wins 2020 R&D100 Award
... on a process developed by Dr. Cary Pint’s laboratory and makes use of high-value secondary material produced from greenhouse gases and ...
sommers - 10/30/2020 - 12:46pm
-
Study shows new COVID target could improve vaccines
... impressive vaccination effort that exceeds 2 million shots a day, rates of COVID-19 are again on the rise in several parts of the United ...
sommers - 04/12/2021 - 10:52am
-
Ancora Innovation Announces Second RFP Process March 14
02/20/2019 ...
sommers - 03/14/2019 - 1:09pm
-
Designing antibodies to fight the flu
02/06/2019 ...
sommers - 02/21/2019 - 9:51am
-
Insulin accelerant
10/23/2018 ...
sommers - 02/21/2019 - 9:51am
-
Cellular stress defense
10/23/2018 ...
sommers - 02/21/2019 - 9:51am
-
Targeting diabetic kidney disease
10/23/2018 ...
sommers - 02/21/2019 - 9:51am